RSSLetters to the Editor

Letter to the Editor: Kratom and the Opioid Crisis

Letter to the Editor: Kratom and the Opioid Crisis

| May 1, 2018 | 0 Comments

Innov Clin Neurosci. 2018;15(5–6):11–12 Dr. Bestha is with the Carolinas Healthcare System in Charlotte, North Carolina. Funding/financial disclosures. The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: On October 26, 2017, the opioid crisis was declared a public […]

Continue Reading

Letter to the Editor: Discussing ANT1 role in Amyotrophic Lateral Sclerosis pathogenesis

Letter to the Editor: Discussing ANT1 role in Amyotrophic Lateral Sclerosis pathogenesis

| April 1, 2018 | 0 Comments

Continue Reading

Letter to the Editor: Olanzapine and Diabetic Ketoacidosis: What is the Underlying Mechanism?

Letter to the Editor: Olanzapine and Diabetic Ketoacidosis: What is the Underlying Mechanism?

| April 1, 2018 | 0 Comments

Continue Reading

Letter to the Editor: Prolactin levels in Patients with Schizophrenia who were switched from daily to once-monthly Aripiprazole treatment

Letter to the Editor: Prolactin levels in Patients with Schizophrenia who were switched from daily to once-monthly Aripiprazole treatment

| April 1, 2018 | 0 Comments

Continue Reading

Letter to the Editor: Pneumocephalus: Is the needle size  significant?

Letter to the Editor: Pneumocephalus: Is the needle size significant?

| February 1, 2018 | 0 Comments

Continue Reading

Letter to the editor: Marijuana on the brain— a concern

Letter to the editor: Marijuana on the brain— a concern

| February 1, 2018 | 0 Comments

Continue Reading

Letter to the editor: Stroke Telerehabilitation in Sicily: a cost-effective approach to reduce disability?

Letter to the editor: Stroke Telerehabilitation in Sicily: a cost-effective approach to reduce disability?

| February 1, 2018 | 0 Comments

Continue Reading

An Open-Label Prophylaxis Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) Combination for Rapid Cycling Bipolar Disorder

An Open-Label Prophylaxis Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) Combination for Rapid Cycling Bipolar Disorder

| September 1, 2017 | 0 Comments

by Sriram Ramaswamy, MD; David Driscoll, PhD; and Lynette M. Smith, PhD Dr. Ramaswamy is with the Department of Psychiatry, Creighton University School of Medicine, Omaha, Nebraska, and the VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska. Dr. Driscoll is with the VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska. Dr. Smith is with the […]

Continue Reading